Viral and other exotic diseases may be transmitted by blood transfusion. These infections include human immunodeficiency virus (HIV), hepatitis viruses (A, B, C, D and E), syphilis, malaria, retrovirus HTLV-1, and cytomegalovirus. Other more exotic diseases which may be transmitted by transfusion of blood or blood components include Chagas’ disease (Trypanosomiasis cruzi), Lyme disease (Borrelia burgdorferi), and Jakob-Creutzfeldt disease.
Screening procedures currently used in Australian blood banks minimise transfusion-transmitted infection. The risk of acquiring any infection in this manner may be less than 0.1%.
NekweiN., ColebundersR.L., BahweY.Acute manifestations of HIV infection following blood transfusion.IV International Conference on AIDS, Stockholm1988; 2: 350.
2.
KleinmanS.The Transfusion Safety Study Group. The Infectivity of Anti-HIV Positive Blood Components. 11 International Conference on AIDS.Washington DC1987; 101.
3.
ArcherG.T., BoltonW.V., CookL.HIV infection in patients following blood transfusion.IV International Conference on AIDS, Stockholm1988; 2: 354.
4.
BrassA., GoldJ.AIDS and Australia.Bay Books1985.
5.
WylieB.R.HIV and Blood Transfusion.Today's Life Science1992, 4; 6: 72–76.
6.
GarsiaR.J., GatenbyP.A., BastenA.Australian Haemophiliac Recipients of Voluntary Donor Blood Products Longitudinally Evaluated for AIDS. A Clinical and Laboratory Study, 1983–1986.Aust NZ J Med1987; 17: 371–378.
7.
KaldorJ., WhyteB., ArcherG.Human immunodeficiency virus antibodies in sera of Australian blood donors, 1985–1990.Med J Aust1991; 155: 297–300.
8.
ClavelF., GuetardD., Brun-VezinetF.Isolation of a new human retrovirus from West African patients with AIDS.Science1986; 233: 343–346.
9.
DownieJ.C., CunninghamA.L., LevyM.Human Immunodeficiency Virus Type 2 in Sydney.Aust HIV Surveillance Report1992; 8: 1.
10.
JanotC., CourouceA.p24 Antigen in plasma donations collected before the discovery of anti-HIV seropositivity.VIII International Conference on AIDS, Florence1991; 2: 366.
11.
WardJ.W., HolmbergS.D., AllenJ.R.Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody.N Engl J Med1988; 318: 473.
12.
ZuckT.F.Transfusion Transmitted AIDS Reassessed.N Engl J Med1988; 318: 511–512.
13.
SimondsR.J., HolmbergS.D., HurwitzR.L.Transmission of Human Immunodeficiency Virus Type I from a seronegative organ and tissue donor, New Engl J Med1992; 326: 726–732.
14.
AlterH.J., EpsteinJ.S., SwensonS.G.Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. blood donors—An assessment of the efficacy of testing in donor screening.N Engl J Med1990; 323: 1312–1317.
15.
BackerU., WeinauerF., GathofA.G.HIV Antigen screening in blood donors.IV International Conference on AIDS, Stockholm1988; 2: 364.
16.
IraniM.S., DudleyA.W., LuccoL.J.Case of HIV-1 transmission by antigen-positive, antibody-negative blood.N Engl J Med1991; 325: 1174–1175.
17.
ChiewsilpP., IsarangkuraP., PoonkasemA.Risk of transmission of HIV by seronegative blood.Lancet1991; ii: 1341.
18.
HonlingerM., FuchsD., HausenA.Determination of serum neopterin to increase the safety of donated blood for transfusion: results in 76587 blood donors.Dtsch Med Wschr1989; 114: 172–176.
19.
Le PontF., MassariV., JullienA.Anti-HBc testing can decrease the residual risk of transfusion-related HIV transmission by more than one third.Vox Sang1990; 59: 248–250.
20.
LoiaconoB.R., CarterG.R., CartrerS.F.Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood donations.Transfusion1989; 29: 823–826.
21.
Blood Bank Week1992; 12: 1–3.
22.
ChooQ.L., KouG., WeinerA.J.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science1989; 244: 359–361.
23.
BradleyD.W.Hepatitis E. Epidemiology,Actiology and Molecular Biology Reviews in Medical Virology1992; 19–28.
24.
NobleR.C., KaneM.A., ReevesS.A., RoeckelI.Post-transfusion hepatitis A in a neonatal intensive care unit.JAMA1984; 252: 2711–2715.
25.
SherertzR.J., RussellB.A., ReumanP.D.Transmission of hepatitis A by transfusion of blood products.Arch Intern Med1984; 144: 1579–1580.
26.
SeebergS., BrandbergA., HermodssonS.Hospital outbreak of hepatitis A secondary to blood exchange in a baby.Lancet1981; i: 1155–1156.
27.
ShihW.K., EstebanJ.I., AlterH.J.Non-A Non-B hepatitis: Advances and unfulfilled expectations of the first decade.Prog Liver Dis1986; 8: 433–452.
28.
WylieB.R., and LienA.Hepatitis B Core Antibody in Blood Donors (Abs).Australasian Society of Blood Transfusion Meeting, Melbourne1991.
29.
CossartY.E., KirschS., IsmayS.L.Post-transfusion hepatitis in Australia.Lancet1982; i: 208–213.
30.
CossartY.E.Personal Communication1992.
31.
KuoG., ChooQ.L., AlterH.J.An assay for circulating antibodies to a major etiological virus of human non-A, non-B hepatitis.Science1989; 244: 362–364.
32.
AlterH.J., PurcellR.H., ShihJ.W.Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.N Eng J Med1989; 321: 1494–1500.
33.
RizzettoM., PonzettoA., MarinucciG.Transfusion-related delta hepatitis.Trans Med Rev1988; 2: 224–228.
34.
RosinaF., SaraccoG., RizzettoM.Risk of post-transfusion infection with the hepatitis delta virus. N.Engl J Med1985; 312: 1488–1491.
35.
BarnesA.Transfusion-Transmitted Treponemal Infections in Transfusion Transmitted Infections.SmithD.M., and DoddRY eds. ASCP Press, Chicago1991.
36.
QuinnT.C., GlasserD., CannonR.D.Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases.N Engl J Med1988; 318: 197–203.
37.
Standards for Blood Banks and Transfusion Services.AABB, 14th Edition, 1991; 17.
38.
GuerreroI.C., WenigerB.C., SchultzM.G.Transfusion malaria in the United States, 1972–1981.Ann Intern Med1983; 99: 221–226.
39.
Communicable Diseases Intelligence1992; 16: 283.
40.
WhyteG.Personal communication1992.
41.
WestphalR.Transfusion-transmitted malarial infections in transfusion transmitted infections.SmithD.M., and DoddRY eds. ASCP PressChicago, 1991.
42.
WellsL., AlaF.A.Malaria and blood transfusion.Lancet1985; 1: 1317–1318.
43.
NajemG.R., SulzerA.J.Transfusion-induced malaria from an asymptomatic carrier.Transfusion1976; 16: 473–476.
44.
Transfusion Malaria: Serologic Identification of Infected Donours.Pennsylvania, Georgia.MMWR1983; 32: 222–229.
45.
PoieszB.J., RuscettiF.W., GazdarA.F.Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.Proc Natl Acad Sci USA1980; 77: 7415–7419.
46.
RatnerL., PoieszB.J.Leukaemias Associated with Human T-Cell Lymphotropic Virus Type I in a non-endemic region.Medicine1988; 67: 401–422.
47.
KazuraJ.W., SaxingerW.C., WengerJ.Epidemiology of Human T-Cell Leukaemia Virus Type I Infection in East Sepik Province, Paper New Guinea.J Inf Diseases1987; 155: 1100–1107.
48.
MayJ.T., StentG., and SchnagelR.D.Antibody to human T-cell lymphotropic virus type I in Australian Aborigines.Med J Aust1988; 149: 104.
49.
KirklandM.A., FrascaJ., BastianI.Adult T-cell leukaemia lymphoma in an Aborigine.Aus NZ J Med1991; 21: 739–741.
50.
NicholsonS., EfandisT., DimitrakakisM.HTLV-I infection in selected populations in Australia and the Western Pacific region.Med J Aust1992; 156: 878–880.
51.
KimberR.J.Personal Communication1992.
52.
SandlerS.G., FangC.T., and WilliamsA.E.Human T-Cell Lymphotropic Virus Type I and II in Transfusion Medicine.Trans Med Reviews1991; 2: 93–107.
53.
ChenY.A., LeeT., WiktorS.Z.Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.Lancet1990; ii: 1153–1155.
54.
RosenblattJ.D., GoldeD.W., WachsmanW.A second isolate of HTLV-II associated with atypical hairy cell leukaemia.N Engl J Med1986; 315: 32–35.
55.
KalyanaramanV.S., SarngadharanM.G., Robert-GuroffM.A new subtype of human T-cell leukaemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukaemia.Science1982; 218: 571–573.
56.
OnoratoI.M., MorensD.M., MartoneW.J.Epidemiology of cytomegaloviral infections: Recommendations for prevention and control.Rev Infect Dis1985; 7: 479–497.
57.
RandoR.F., PellettP.A., LuciwP.A.Transactivation of human immunodeficiency virus by herpes virus.Oncogene1987; 1: 13–18.
58.
YeagerA.S., PalumboP.E., MalachowskiN.Sequelae of maternally derived cytomegalovirus infections in premature infants.J Pediatr1983; 102: 918–922.
59.
GilbertG.L., HayesK., HudsonI.L.Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes.Lancet1989; 1: 1228–1231.
60.
LambersonH.V., DockN.L.Prevention of transfusion transmitted cytomegalovirus infection.Transfusion1991; 32: 196–198.
61.
SchmunisG.A.Chagas’ disease and blood transfusion; in Infection, Immunity and Blood Transfusion.DoddRY ed. New York: Alan R Liss Inc1985.
62.
GrantI.H., GoldJ.W.M., WittnerM.Transfusion-associated acute Chagas’ disease acquired in the United States.Ann Intern Med1989; 111: 849–851.
63.
NickersonP., OrrP., SchroederM.L.Transfusion-associated Trypanosoma cruzi infection in a non-endemic area.Ann Intern Med1989; 11: 851–853.
64.
AokiS.K., HollandP.L.Lyme disease: Another transfusion risk?Transfusion1989; 29: 646–650.
65.
BadonS.J., FisterR.D., CableR.G.Survival of Borrelia burgdorferi in blood products.Transfusion1989; 29: 581–583.
66.
SchwartzB.S., GoldsteinM.D., RibeiroJ.M.C.Antibody testing in Lyme disease, a comparison of results in four laboratories.JAMA1989; 262: 3431–3434.
67.
StewartA., GlassJ., PatelA.Lyme arthritis in the Hunter Valley.Med J Aust1982; 1: 139.
68.
McCrossinI.Lyme disease on the NSW south coast.Med J Aust1986; 144: 724–725.
69.
LawrenceR.H., BradburyR., CullenJ.S.Lyme disease on the central coast.Med J Aust1986; 145: 364.
